Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Europe
0
Canada
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Finished Drug Prices
NA
1. Gtpl9416
2. Isis396443
Molecular Weight | 7127 g/mol |
---|---|
Molecular Formula | C234H340N61O128P17S17 |
XLogP3 | -14.4 |
Hydrogen Bond Donor Count | 40 |
Hydrogen Bond Acceptor Count | 167 |
Rotatable Bond Count | 176 |
Exact Mass | 7124.2829700 g/mol |
Monoisotopic Mass | 7122.2762603 g/mol |
Topological Polar Surface Area | 2820 Ų |
Heavy Atom Count | 457 |
Formal Charge | 0 |
Complexity | 19100 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 72 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2036-03-04
US Patent Number : 12013403
Drug Substance Claim :
Drug Product Claim :
Application Number : 209531
Patent Use Code : U-2093
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-03-04
Patent Expiration Date : 2035-09-11
US Patent Number : 10436802
Drug Substance Claim :
Drug Product Claim :
Application Number : 209531
Patent Use Code : U-1944
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-09-11
Patent Expiration Date : 2025-12-05
US Patent Number : 10266822
Drug Substance Claim :
Drug Product Claim :
Application Number : 209531
Patent Use Code : U-1944
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-12-05
Patent Expiration Date : 2036-03-04
US Patent Number : 12013403
Drug Substance Claim :
Drug Product Claim :
Application Number : 209531
Patent Use Code : U-2094
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-03-04
Patent Expiration Date : 2035-09-11
US Patent Number : 10436802
Drug Substance Claim :
Drug Product Claim :
Application Number : 209531
Patent Use Code : U-1942
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-09-11
Patent Expiration Date : 2025-12-05
US Patent Number : 10266822
Drug Substance Claim :
Drug Product Claim :
Application Number : 209531
Patent Use Code : U-1942
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-12-05
Patent Expiration Date : 2030-11-24
US Patent Number : 8980853
Drug Substance Claim :
Drug Product Claim :
Application Number : 209531
Patent Use Code : U-1941
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-11-24
Patent Expiration Date : 2030-06-17
US Patent Number : 9717750
Drug Substance Claim :
Drug Product Claim :
Application Number : 209531
Patent Use Code : U-1943
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-06-17
Patent Expiration Date : 2025-12-05
US Patent Number : 8110560
Drug Substance Claim :
Drug Product Claim :
Application Number : 209531
Patent Use Code : U-1942
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-12-05
Patent Expiration Date : 2025-12-05
US Patent Number : 10266822
Drug Substance Claim :
Drug Product Claim :
Application Number : 209531
Patent Use Code : U-1943
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-12-05
ABOUT THIS PAGE
A Nusinersen Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nusinersen Sodium, including repackagers and relabelers. The FDA regulates Nusinersen Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nusinersen Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nusinersen Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nusinersen Sodium supplier is an individual or a company that provides Nusinersen Sodium active pharmaceutical ingredient (API) or Nusinersen Sodium finished formulations upon request. The Nusinersen Sodium suppliers may include Nusinersen Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Nusinersen Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nusinersen Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nusinersen Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nusinersen Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nusinersen Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nusinersen Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nusinersen Sodium suppliers with NDC on PharmaCompass.
Nusinersen Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nusinersen Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nusinersen Sodium GMP manufacturer or Nusinersen Sodium GMP API supplier for your needs.
A Nusinersen Sodium CoA (Certificate of Analysis) is a formal document that attests to Nusinersen Sodium's compliance with Nusinersen Sodium specifications and serves as a tool for batch-level quality control.
Nusinersen Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Nusinersen Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nusinersen Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Nusinersen Sodium EP), Nusinersen Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nusinersen Sodium USP).
LOOKING FOR A SUPPLIER?